You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • Correction: Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

https://doi.org/10.1136/rmdopen-2021-001838corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    McInnes IB, Kato K, Magrey M, et al. Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study. RMD Open 2021;7:e001838. doi: 10.1136/rmdopen-2021-001838

    In this article, the author name 'Frank Behrens' was incorrectly spelt as 'Franck Behrens'. This has now been corrected online.